Maximino Redondo | Health Professions | Best Scholar Award

Prof. Dr. Maximino Redondo | Health Professions | Best Scholar Award

Prof. Dr. Maximino Redondo, Universidad de Málaga, Spain

Dr. Maximino Redondo Bautista is an accomplished Spanish physician and professor, with an extensive career in clinical laboratory medicine and health research. Since 1993, he has served as a Medical Specialist at Hospital Universitario Costa del Sol in Málaga, while concurrently advancing academia as a full-time professor at the University of Málaga. With six recognized research sexennia and leadership of the hospital’s Research Unit, Dr. Redondo has made significant strides in translational medicine, oncology, and chronic disease studies. He has led 18 competitive research projects supported by the Instituto de Salud Carlos III and regional health bodies. His international collaborations and contributions to multicenter studies have shaped evidence-based healthcare practices in Spain. Through consistent involvement in national research networks like REDISSEC and RICAPPS, he promotes innovation, training, and the implementation of real-world healthcare solutions.

Profile

Google Scholar

🌟 Assessment of Suitability for the Research for Best Scholar Award: Dr. Maximino Redondo Bautista

Summary of Suitability:

Dr. Maximino Redondo Bautista stands as a highly qualified candidate for the Research for Best Scholar Award, bringing decades of academic, clinical, and research excellence to the forefront. With a strong dual appointment as a Medical Specialist at the Hospital Universitario Costa del Sol since 1993 and a Full Professor (Catedrático) at the University of Málaga since 2023, his contributions straddle both advanced medical practice and academic leadership.

Dr. Redondo earned his Doctorate in Medicine and Surgery from the University of Granada in 1991, along with specialized academic training in Epidemiology and Clinical Research. His professional journey reflects a consistent climb, with long-term involvement in academia and research, having held multiple professorial roles and received continuous competitive research funding. Over the years, he has served as Principal Investigator in 18 competitive research projects funded by the Instituto de Salud Carlos III and the Andalusian Health Council.

🎓 Education

Dr. Redondo holds a Doctorate in Medicine and Surgery from the University of Granada (1991), which laid the groundwork for his specialization in clinical analysis and translational medical research. He also earned a University Expert Degree in Epidemiology and Clinical Research from the same university in 2000. His academic journey began with a residency (MIR) in Clinical Analysis at the University Hospital Virgen de las Nieves (1986–1990), followed by key professional training in top Spanish medical centers. Over the years, he has cultivated a strong background in biomedical sciences and public health, supported by further academic certification and participation in national programs. His extensive formal education, complemented by teaching roles since 1992, has empowered him to nurture emerging scientists, shape academic curricula, and contribute to policy-oriented research in health sciences.

💼 Professional Experience

Dr. Maximino Redondo has more than three decades of experience in clinical medicine, research, and higher education. Since 1993, he has worked as a Clinical Laboratory Specialist at Hospital Universitario Costa del Sol. In academia, he has been a professor at the University of Málaga since 1992, most recently serving as Chair Professor in the Department of Surgical Specialties, Biochemistry, and Immunology. He also served as a Tenured Professor and Associate Professor over the years. His extensive career includes significant research leadership: serving on competitive programs at Instituto de Salud Carlos III and the Andalusian Health Council. He coordinates national research networks, leads clinical studies, and contributes to translational research initiatives. Dr. Redondo’s integrated professional approach bridges patient care, scientific inquiry, and academic excellence, shaping policy and fostering innovation in health service delivery.

🏅 Awards and Recognition 

Dr. Redondo has been widely recognized for his exceptional contributions to biomedical research, health policy, and academic mentorship. His work has earned six officially recognized sexenios de investigación (six-year research productivity periods), a distinguished mark in Spanish academia. He has led 18 competitive research projects and was repeatedly selected for national Intensification Programs by both Instituto de Salud Carlos III and the Andalusian Ministry of Health. Dr. Redondo played a central role in the REDISSEC and RICAPPS research networks, coordinating multicenter studies and leading national healthcare strategies. His efforts have translated research findings into impactful healthcare practices and evidence-based policy reforms. As a principal investigator and mentor, he has contributed to researcher training programs and advanced Spain’s health system through innovation and collaborative research. His influence spans medical education, diagnostics, and national public health frameworks.

🌍 Research Skills On Health Professions

Dr. Redondo excels in translational research, clinical epidemiology, biostatistics, and health services evaluation. His primary focus lies in oncology, chronic illness management, and the integration of research findings into real-world clinical practice. His skillset includes designing multicenter studies, applying evidence-based medicine, and leveraging laboratory diagnostics to inform health policies. As a senior researcher and group leader in the RICAPPS (RD21/0016/0015 and RD24/0005/0016) and REDISSEC networks, he coordinates collaborative research among hospitals, universities, and institutes across Spain. He also mentors early-career researchers, promotes interdisciplinary partnerships, and strengthens knowledge translation in healthcare. His ability to secure competitive funding and lead innovative health projects demonstrates scientific and managerial expertise. Dr. Redondo also contributes to editorial, evaluation, and strategic committees, ensuring the long-term sustainability and impact of research initiatives aimed at improving public health outcomes.

📖 Publication Top Notes

  • 🔬 Overexpression of clusterin in human breast carcinoma
    Authors: M. Redondo, E. Villar, J. Torres-Muñoz, T. Tellez, M. Morell, C.K. Petito
    Citation: The American Journal of Pathology, 157(2), 393–399.
    Year: 2000

  • 🧪 Immunotherapy: a challenge of breast cancer treatment
    Authors: M. García-Aranda, M. Redondo
    Citation: Cancers, 11(12), 1822.
    Year: 2019

  • 🧫 Expression of prostate specific membrane antigen (PSMA) in prostatic adenocarcinoma and prostatic intraepithelial neoplasia
    Authors: C. Marchal, M. Redondo, M. Padilla, J. Caballero, I. Rodrigo, J. Garcia, et al.
    Citation: Histology and Histopathology, 2004.
    Year: 2004

  • 🧠 Deletion of lysophosphatidic acid receptor LPA1 reduces neurogenesis in the mouse dentate gyrus
    Authors: E. Matas-Rico, B. Garcia-Diaz, P. Llebrez-Zayas, D. López-Barroso, L. Santin, M. Redondo, et al.
    Citation: Molecular and Cellular Neuroscience, 39(3), 342–355.
    Year: 2008

  • 💉 Bcl-2 inhibition to overcome resistance to chemo- and immunotherapy
    Authors: M. García-Aranda, E. Pérez-Ruiz, M. Redondo
    Citation: International Journal of Molecular Sciences, 19(12), 3950.
    Year: 2018

  • 🧬 Presence of HPV 16 sequences in laryngeal carcinomas
    Authors: M. Perez-Ayala, F. Ruiz-Cabello, F. Esteban, A. Concha, M. Redondo, et al.
    Citation: International Journal of Cancer, 46(1), 8–11.
    Year: 1990

  • 🧻 The substance P/NK-1 receptor system: NK-1 receptor antagonists as anti-cancer drugs
    Authors: M. Muñoz, R. Coveñas, F. Esteban, M. Redondo
    Citation: Journal of Biosciences, 40, 441–463.
    Year: 2015

  • 🫁 Expression of HLA class I and II antigens in bronchogenic carcinomas: its relationship to cellular DNA content and clinical-pathological parameters
    Authors: M. Redondo, A. Concha, R. Oldiviela, A. Cueto, A. Gonzalez, F. Garrido, et al.
    Citation: Cancer Research, 51(18), 4948–4954.
    Year: 1991

  • 🔬 NK-1 receptor antagonists induce apoptosis and counteract substance P-related mitogenesis in human laryngeal cancer cell line HEp-2
    Authors: M. Muñoz, M. Rosso, F.J. Aguilar, M.A. González-Moles, M. Redondo, et al.
    Citation: Investigational New Drugs, 26, 111–118.
    Year: 2008

  • 🎯 Protein kinase targets in breast cancer
    Authors: M. García-Aranda, M. Redondo
    Citation: International Journal of Molecular Sciences, 18(12), 2543.
    Year: 2017

Dr. Yucheng Cao | Nursing | Best Researcher Award

Dr. Yucheng Cao | Nursing | Best Researcher Award

👤 Dr. Yucheng Cao, Johns Hopkins Bloomberg School of Public Health, United States

Yucheng Cao is a distinguished professional in health policy and management, specializing in public health and nursing. With extensive experience in both medical and financial sectors, Cao currently serves as the Deputy General Manager at Guangci Medical & Nursing in Hangzhou, China. Holding a Doctor of Public Health (Dr.P.H.) and Master of Health Science (M.H.S.) from Johns Hopkins University, Cao’s academic background is enriched by degrees in nursing, health care management, and international business. His career journey spans analytical roles at Merrill Lynch, cardiology internships, and committee membership across leading health and genetic organizations. Cao’s research focuses on enhancing nursing practices and healthcare policies, and he has contributed valuable insights through peer-reviewed publications and conferences. Known for his dedication to improving healthcare systems, Cao continues to make significant contributions to the fields of health policy and nursing innovation.

Professional Profile

orcid

🌟 Summary of Suitability for the Research for Best Researcher Award

Yucheng Cao is a highly suitable candidate for the Research for Best Researcher Award due to his extensive academic background, professional experience, and significant contributions to the fields of health policy, nursing, and public health. Holding multiple advanced degrees, including an anticipated Doctor of Public Health (Dr.P.H.) and a Master of Health Science from Johns Hopkins University, Cao demonstrates a commitment to advanced research and specialized knowledge in health policy and management. His diverse educational background, which includes degrees in public health, nursing, health care management, and business, provides a strong foundation for interdisciplinary research and application in real-world health settings.

🎓 Education

Yucheng Cao’s academic journey is marked by excellence in health science and business management. He earned a Doctor of Public Health (Dr.P.H.) and a Master of Health Science (M.H.S.) from the prestigious Johns Hopkins University, Bloomberg School of Public Health, with a major in Health Policy and Management. His foundation in healthcare began with a Bachelor of Science in Nursing (B.S.N.) from Panzhihua University in Sichuan. Further strengthening his expertise, Cao pursued a Master of Public Health (M.P.H.) from the Icahn School of Medicine at Mount Sinai, focusing on Health Care Management. His academic pursuits also include a Master of Business Administration (M.B.A.) from Concordia University Wisconsin, where he specialized in International Business. This diverse educational background equips him with a unique blend of healthcare and business knowledge, enabling him to approach health policy with a holistic and globally aware perspective.

💼   Professional Experience

Yucheng Cao brings a wealth of professional experience spanning healthcare management, finance, and compliance. Since 2016, he has been the Deputy General Manager at Guangci Medical & Nursing in Hangzhou, China, where he leads initiatives to improve nursing standards and patient care. Previously, Cao served as an Analyst at Merrill Lynch in Manhattan, New York, where he gained insights into financial analysis and strategic planning. His experience also includes a cardiology internship at Mount Sinai Hospital and internships at HSBC and China Life Insurance, where he honed skills in legal compliance and risk management. Cao’s international experience and multifaceted roles underscore his ability to navigate complex healthcare and financial systems, making him a highly adaptable and innovative leader. His role in healthcare management is strengthened by a deep understanding of policy, finance, and operations, contributing to his reputation as a versatile professional in the healthcare industry.

🏅 Awards and Recognitions 

Yucheng Cao has garnered several prestigious recognitions for his contributions to healthcare and finance. His professional achievements include fellowships with the American Academy of Financial Management and committee positions within the Genetic Society of China and the Zhejiang Life and Health Industry Innovation Committee. Notably, Cao is a Certified Risk Analyst, Registered Business Analyst, and Registered Financial Planner, all certified by the American Academy of Financial Management. His international acclaim includes serving as a BIM Architect Instructor and earning multiple certifications that underscore his expertise in risk and business analysis. His notable invited presentations, such as his address at the 5th International Specialty Nurse Conference in Hangzhou, further illustrate his leadership in advancing global healthcare practices. Cao’s accolades reflect his commitment to excellence and his influence in both the medical and financial sectors, solidifying his status as a highly respected figure in health policy and management.

🌍 Research Skills On Nursing

Yucheng Cao is skilled in research methodologies that advance healthcare policy, nursing practices, and quality management. His expertise includes quantitative analysis, risk assessment, and healthcare data interpretation, allowing him to navigate complex health systems effectively. Cao’s research in occupational burnout among Chinese nurses has garnered attention for its focus on nursing work environments and perceived care quality, highlighting his dedication to improving healthcare workplace standards. His multidisciplinary background in business and health sciences enables him to approach research with a strategic, data-driven perspective. Cao’s familiarity with public health, coupled with his financial analysis skills, makes him proficient in developing policies that balance cost efficiency with patient care quality. This diverse skill set positions him as a valuable contributor to academic research and health policy reform, emphasizing his ability to bridge practical healthcare needs with evidence-based research insights.

📖 Publication Top Notes

Differentiating Occupational Burnout Among Chinese Nurses: Moderating Roles in Nursing Work Environment and Perceived Care Quality
    • Authors: Yucheng Cao, Qiwei Wu, Leiyu Shi, Yu Gao, Kathy Chappell, Jing Shao
    • Year: 2024
Medical-Surgical Nursing Practice
    • Author: Yucheng Cao, DrPH(c), MBA, BSN
    • Year: 2022
Nursing Practice of Tumor
    • Author: Yucheng Cao, DrPH(c), MBA, BSN
    • Year: 2022
Drawing Lessons from Foreign Nursing Assistants to Empower Elderly Care in China
    • Author: Yucheng Cao, DrPH(c), MBA, BSN
    • Year: 2021
Nursing Practice of Emergency
    • Author: Yucheng Cao, DrPH(c), MBA, BSN
    • Year: 2021